

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.98944807 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.30557367 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.30557367 |
| 4 | NIK/NF-kappaB signaling (GO:0038061) | 4.29255510 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.23975468 |
| 6 | positive regulation of antigen processing and presentation (GO:0002579) | 4.08089798 |
| 7 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.96590493 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 3.83672911 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 3.73224856 |
| 10 | regulation of antigen processing and presentation (GO:0002577) | 3.58788011 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.54985856 |
| 12 | cellular response to zinc ion (GO:0071294) | 3.48468700 |
| 13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.41596669 |
| 14 | myeloid dendritic cell differentiation (GO:0043011) | 3.38574784 |
| 15 | detection of bacterium (GO:0016045) | 3.36063552 |
| 16 | myeloid dendritic cell activation (GO:0001773) | 3.34007532 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32462678 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31411792 |
| 19 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27868438 |
| 20 | response to interferon-beta (GO:0035456) | 3.27483309 |
| 21 | B cell mediated immunity (GO:0019724) | 3.25205720 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 3.24550988 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.21441676 |
| 24 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.18838409 |
| 25 | regulation of RIG-I signaling pathway (GO:0039535) | 3.16413654 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 3.16257894 |
| 27 | dendritic cell differentiation (GO:0097028) | 3.16117889 |
| 28 | detection of other organism (GO:0098543) | 3.15039971 |
| 29 | cellular response to interferon-beta (GO:0035458) | 3.08249206 |
| 30 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05864536 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 3.05225400 |
| 32 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.04932194 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.04194705 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.02107146 |
| 35 | cellular response to type I interferon (GO:0071357) | 3.02107146 |
| 36 | response to type I interferon (GO:0034340) | 2.99772728 |
| 37 | neutrophil activation (GO:0042119) | 2.95445751 |
| 38 | interferon-gamma secretion (GO:0072643) | 2.90725798 |
| 39 | positive regulation of interleukin-12 production (GO:0032735) | 2.90672871 |
| 40 | regulation of hypersensitivity (GO:0002883) | 2.90542012 |
| 41 | positive thymic T cell selection (GO:0045059) | 2.90084734 |
| 42 | thymic T cell selection (GO:0045061) | 2.89109899 |
| 43 | cellular response to exogenous dsRNA (GO:0071360) | 2.89028633 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 2.87643340 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86257886 |
| 46 | negative regulation of cell killing (GO:0031342) | 2.85858312 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85858312 |
| 48 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85354721 |
| 49 | defense response to protozoan (GO:0042832) | 2.84823589 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84150654 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81981742 |
| 52 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.81104625 |
| 53 | granulocyte activation (GO:0036230) | 2.78248352 |
| 54 | respiratory burst (GO:0045730) | 2.76050242 |
| 55 | response to muramyl dipeptide (GO:0032495) | 2.75424200 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75245600 |
| 57 | regulation of B cell differentiation (GO:0045577) | 2.73386219 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70724450 |
| 59 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68938260 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 2.68762628 |
| 61 | response to protozoan (GO:0001562) | 2.68597937 |
| 62 | Golgi transport vesicle coating (GO:0048200) | 2.67949908 |
| 63 | COPI coating of Golgi vesicle (GO:0048205) | 2.67949908 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67681182 |
| 65 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.67340497 |
| 66 | natural killer cell mediated immunity (GO:0002228) | 2.67340497 |
| 67 | response to peptidoglycan (GO:0032494) | 2.66998333 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66865246 |
| 69 | regulation of superoxide anion generation (GO:0032928) | 2.66008120 |
| 70 | negative thymic T cell selection (GO:0045060) | 2.65993780 |
| 71 | germinal center formation (GO:0002467) | 2.65990292 |
| 72 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.64578257 |
| 73 | regulation of necroptotic process (GO:0060544) | 2.62680850 |
| 74 | positive regulation of neutrophil migration (GO:1902624) | 2.61776439 |
| 75 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.61776439 |
| 76 | leukocyte mediated cytotoxicity (GO:0001909) | 2.60892718 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.60765398 |
| 78 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.60362122 |
| 79 | regulation of interleukin-12 production (GO:0032655) | 2.57985188 |
| 80 | T cell costimulation (GO:0031295) | 2.57016566 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 2.56856112 |
| 82 | pinocytosis (GO:0006907) | 2.56698236 |
| 83 | dendritic cell chemotaxis (GO:0002407) | 2.55859989 |
| 84 | response to host immune response (GO:0052572) | 2.55313476 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55313476 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.54767945 |
| 87 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.53995590 |
| 88 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.53771208 |
| 89 | lymphocyte costimulation (GO:0031294) | 2.53498965 |
| 90 | mannose metabolic process (GO:0006013) | 2.53050810 |
| 91 | B cell homeostasis (GO:0001782) | 2.52043587 |
| 92 | modulation by symbiont of host cellular process (GO:0044068) | 2.51703897 |
| 93 | T-helper 1 type immune response (GO:0042088) | 2.51545614 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.50712221 |
| 95 | DNA deamination (GO:0045006) | 2.50323515 |
| 96 | regulation of natural killer cell differentiation (GO:0032823) | 2.49210429 |
| 97 | viral transcription (GO:0019083) | 2.48958836 |
| 98 | regulation of mast cell degranulation (GO:0043304) | 2.48788184 |
| 99 | T cell migration (GO:0072678) | 2.47510795 |
| 100 | modulation by virus of host process (GO:0019054) | 2.47126277 |
| 101 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.46070462 |
| 102 | cellular response to virus (GO:0098586) | 2.45517697 |
| 103 | regulation of activation of Janus kinase activity (GO:0010533) | 2.45288788 |
| 104 | amino sugar catabolic process (GO:0046348) | 2.44753365 |
| 105 | proline biosynthetic process (GO:0006561) | 2.44372046 |
| 106 | response to interferon-alpha (GO:0035455) | 2.43349675 |
| 107 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.43206963 |
| 108 | response to interferon-gamma (GO:0034341) | 2.41966737 |
| 109 | negative T cell selection (GO:0043383) | 2.41694929 |
| 110 | positive regulation of type 2 immune response (GO:0002830) | 2.39546509 |
| 111 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39150197 |
| 112 | detection of external biotic stimulus (GO:0098581) | 2.38857891 |
| 113 | hepatocyte apoptotic process (GO:0097284) | 2.37938643 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.37864911 |
| 115 | NADH metabolic process (GO:0006734) | 2.37818464 |
| 116 | T cell selection (GO:0045058) | 2.37754090 |
| 117 | response to host (GO:0075136) | 2.36955185 |
| 118 | response to host defenses (GO:0052200) | 2.36955185 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.36955185 |
| 120 | translational termination (GO:0006415) | 2.36235935 |
| 121 | regulation of defense response to virus by virus (GO:0050690) | 2.36198135 |
| 122 | dendritic cell migration (GO:0036336) | 2.35755865 |
| 123 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.35490526 |
| 124 | actin nucleation (GO:0045010) | 2.35308021 |
| 125 | positive regulation of protein homooligomerization (GO:0032464) | 2.35216296 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.35184602 |
| 127 | regulation of necrotic cell death (GO:0010939) | 2.34446681 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34251809 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33780299 |
| 130 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.31543058 |
| 131 | T cell apoptotic process (GO:0070231) | 2.30422434 |
| 132 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.30040418 |
| 133 | positive regulation of interleukin-2 production (GO:0032743) | 2.29974740 |
| 134 | positive regulation of interferon-beta production (GO:0032728) | 2.28856100 |
| 135 | ribosomal small subunit biogenesis (GO:0042274) | 2.28588894 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.28183331 |
| 137 | necroptotic process (GO:0070266) | 2.28062748 |
| 138 | regulation of response to interferon-gamma (GO:0060330) | 2.27730380 |
| 139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.25298648 |
| 140 | angiogenesis involved in wound healing (GO:0060055) | 2.24947178 |
| 141 | negative regulation of growth of symbiont in host (GO:0044130) | 2.24116186 |
| 142 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.24116186 |
| 143 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.24116186 |
| 144 | regulation of growth of symbiont in host (GO:0044126) | 2.24116186 |
| 145 | positive regulation by symbiont of host defense response (GO:0052509) | 2.23286850 |
| 146 | modulation by symbiont of host defense response (GO:0052031) | 2.23286850 |
| 147 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.23286850 |
| 148 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.23286850 |
| 149 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.23286850 |
| 150 | modulation by symbiont of host immune response (GO:0052553) | 2.23286850 |
| 151 | regulation of cellular extravasation (GO:0002691) | 2.22745551 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.22460201 |
| 153 | negative regulation of viral genome replication (GO:0045071) | 2.22387135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75740286 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61228206 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.26392282 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.14149376 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91486730 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63311170 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59516051 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57578264 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47062145 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46209368 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.39837676 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36799516 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28456679 |
| 14 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.25509845 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22324300 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17597276 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15328328 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15320403 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13295300 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11798525 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10709105 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.03773578 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03315499 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03040458 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99692728 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92257448 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.89412440 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87691245 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86366517 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84763601 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83986218 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.79888730 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78218498 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.78139692 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76595062 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76438452 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.70853653 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69243932 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68249778 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67766682 |
| 41 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.66659116 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64846280 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64698215 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63712610 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60622905 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57959133 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55926607 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54138080 |
| 49 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52033463 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51703122 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.51396519 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.43949576 |
| 53 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.43691787 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42970586 |
| 55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42872267 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41216777 |
| 57 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.39260097 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38621425 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37061168 |
| 60 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.36422076 |
| 61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36329464 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35798258 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33573032 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33302015 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32361725 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31821363 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31785608 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.30652019 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30533397 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30500239 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29465951 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28443845 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27041077 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26222053 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24542688 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21670676 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21462679 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20263621 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20219153 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19355682 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18831138 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18255494 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17823837 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17545750 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17420863 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17147475 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16832556 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16667322 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16609920 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16154190 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15846987 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.14894419 |
| 93 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.14542746 |
| 94 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14183800 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13914575 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13783569 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13043616 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12802262 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12452850 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12431475 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12159825 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11724498 |
| 103 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11424609 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11114624 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10727662 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10567348 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07297744 |
| 108 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06771281 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05839238 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04417632 |
| 111 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04047188 |
| 112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03517938 |
| 113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03464174 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02939890 |
| 115 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02412738 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00144659 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.00063204 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99151753 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99061119 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97399439 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97009923 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96672059 |
| 123 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96301763 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96089299 |
| 125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95721472 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95516766 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95398539 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93169954 |
| 129 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93047873 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92830253 |
| 131 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.92428816 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91795743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.69551759 |
| 2 | MP0000685_abnormal_immune_system | 3.43679456 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 2.90040006 |
| 4 | MP0009785_altered_susceptibility_to | 2.86869554 |
| 5 | MP0003436_decreased_susceptibility_to | 2.67046929 |
| 6 | MP0005671_abnormal_response_to | 2.64549472 |
| 7 | MP0001790_abnormal_immune_system | 2.61569276 |
| 8 | MP0005387_immune_system_phenotype | 2.61569276 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.43997181 |
| 10 | MP0005025_abnormal_response_to | 2.41702339 |
| 11 | MP0001800_abnormal_humoral_immune | 2.41156099 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.27512782 |
| 13 | MP0001853_heart_inflammation | 2.25262270 |
| 14 | MP0002419_abnormal_innate_immunity | 2.21877677 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.14983085 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.14557149 |
| 17 | MP0004510_myositis | 2.14397921 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.14164260 |
| 19 | MP0002723_abnormal_immune_serum | 2.12841643 |
| 20 | MP0001819_abnormal_immune_cell | 2.02114098 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.00497286 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.93242439 |
| 23 | MP0001873_stomach_inflammation | 1.88576733 |
| 24 | MP0009840_abnormal_foam_cell | 1.82594442 |
| 25 | MP0006082_CNS_inflammation | 1.82141286 |
| 26 | MP0003724_increased_susceptibility_to | 1.81594038 |
| 27 | MP0002254_reproductive_system_inflammat | 1.78251643 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.77520130 |
| 29 | MP0005310_abnormal_salivary_gland | 1.77481570 |
| 30 | MP0002405_respiratory_system_inflammati | 1.76353902 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.74472886 |
| 32 | MP0002006_tumorigenesis | 1.73083807 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.72690568 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.71582038 |
| 35 | MP0008260_abnormal_autophagy | 1.68861274 |
| 36 | MP0002398_abnormal_bone_marrow | 1.68242740 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.65743833 |
| 38 | MP0000716_abnormal_immune_system | 1.65400942 |
| 39 | MP0003303_peritoneal_inflammation | 1.64901290 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.64480196 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.62028946 |
| 42 | MP0002796_impaired_skin_barrier | 1.55460482 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.48781805 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.48781805 |
| 45 | MP0004947_skin_inflammation | 1.45424314 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.44436123 |
| 47 | MP0002429_abnormal_blood_cell | 1.43636599 |
| 48 | MP0008469_abnormal_protein_level | 1.42309364 |
| 49 | MP0002722_abnormal_immune_system | 1.42116891 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.42004624 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.41756278 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.41170721 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.40107998 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.38123179 |
| 55 | MP0003186_abnormal_redox_activity | 1.32408654 |
| 56 | MP0000490_abnormal_crypts_of | 1.29269811 |
| 57 | MP0000858_altered_metastatic_potential | 1.28214040 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.27710332 |
| 59 | MP0008057_abnormal_DNA_replication | 1.27332062 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.26675240 |
| 61 | MP0009764_decreased_sensitivity_to | 1.24294133 |
| 62 | MP0006054_spinal_hemorrhage | 1.18274322 |
| 63 | MP0000343_altered_response_to | 1.14244023 |
| 64 | MP0005501_abnormal_skin_physiology | 1.12854101 |
| 65 | MP0003866_abnormal_defecation | 1.07066652 |
| 66 | MP0005166_decreased_susceptibility_to | 1.06091725 |
| 67 | MP0003693_abnormal_embryo_hatching | 1.05018045 |
| 68 | MP0003448_altered_tumor_morphology | 1.04866079 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.04542109 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.03633774 |
| 71 | MP0002163_abnormal_gland_morphology | 0.99541953 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 0.99484488 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.98124950 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.97113977 |
| 75 | MP0001346_abnormal_lacrimal_gland | 0.95209160 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.94405453 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.93533289 |
| 78 | MP0004381_abnormal_hair_follicle | 0.92264658 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.91723581 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.90610338 |
| 81 | MP0009278_abnormal_bone_marrow | 0.89686171 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.87496237 |
| 83 | MP0009763_increased_sensitivity_to | 0.87230714 |
| 84 | MP0000678_abnormal_parathyroid_gland | 0.86376990 |
| 85 | MP0003828_pulmonary_edema | 0.84719621 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.83696920 |
| 87 | MP0002933_joint_inflammation | 0.83386077 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.83040218 |
| 89 | MP0001881_abnormal_mammary_gland | 0.81947838 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.81646933 |
| 91 | MP0000609_abnormal_liver_physiology | 0.81401396 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.81383760 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.78186777 |
| 94 | MP0005165_increased_susceptibility_to | 0.78042476 |
| 95 | MP0004858_abnormal_nervous_system | 0.77141900 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.76412891 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.74404660 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.74284521 |
| 99 | MP0003075_altered_response_to | 0.73655307 |
| 100 | MP0002132_abnormal_respiratory_system | 0.72448629 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.72441607 |
| 102 | MP0008007_abnormal_cellular_replicative | 0.72346672 |
| 103 | MP0001663_abnormal_digestive_system | 0.71139407 |
| 104 | MP0000249_abnormal_blood_vessel | 0.70894070 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.70279091 |
| 106 | MP0009931_abnormal_skin_appearance | 0.70052377 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.70002495 |
| 108 | MP0010307_abnormal_tumor_latency | 0.69976721 |
| 109 | MP0008874_decreased_physiological_sensi | 0.68047596 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.67784285 |
| 111 | MP0005023_abnormal_wound_healing | 0.67632966 |
| 112 | MP0000598_abnormal_liver_morphology | 0.67046670 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 0.64912021 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.63547910 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61795176 |
| 116 | MP0005360_urolithiasis | 0.61193546 |
| 117 | MP0005083_abnormal_biliary_tract | 0.59367058 |
| 118 | MP0003077_abnormal_cell_cycle | 0.59074208 |
| 119 | MP0002009_preneoplasia | 0.58613095 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.56579388 |
| 121 | MP0005451_abnormal_body_composition | 0.56291017 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.55776650 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.54928564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.58988625 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.50776052 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.49884378 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.45822901 |
| 5 | Myositis (HP:0100614) | 4.15729201 |
| 6 | Thrombocytosis (HP:0001894) | 4.01988418 |
| 7 | Chronic otitis media (HP:0000389) | 4.01178633 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66162512 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.39304203 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.38790170 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.38790170 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.38790170 |
| 13 | Orchitis (HP:0100796) | 3.37128303 |
| 14 | Recurrent skin infections (HP:0001581) | 3.28462725 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.27252258 |
| 16 | Recurrent viral infections (HP:0004429) | 3.20962063 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.17521496 |
| 18 | Hypertensive crisis (HP:0100735) | 3.08820394 |
| 19 | Petechiae (HP:0000967) | 3.03157678 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.01819960 |
| 21 | Optic neuritis (HP:0100653) | 3.01819960 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01035399 |
| 23 | Recurrent bronchitis (HP:0002837) | 2.96324395 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 2.95121542 |
| 25 | Vasculitis (HP:0002633) | 2.92762579 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 2.92260933 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.91658952 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.91023266 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79187058 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79187058 |
| 31 | IgM deficiency (HP:0002850) | 2.76137322 |
| 32 | Cellulitis (HP:0100658) | 2.74683933 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.72674070 |
| 34 | Pustule (HP:0200039) | 2.66269502 |
| 35 | Inflammation of the large intestine (HP:0002037) | 2.66125818 |
| 36 | Nasal polyposis (HP:0100582) | 2.63798430 |
| 37 | Meningitis (HP:0001287) | 2.62477214 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.60504608 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.56346141 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.56137196 |
| 41 | Colitis (HP:0002583) | 2.54385309 |
| 42 | Ragged-red muscle fibers (HP:0003200) | 2.53331708 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.51635245 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.49886968 |
| 45 | Urticaria (HP:0001025) | 2.47264095 |
| 46 | Abnormal number of erythroid precursors (HP:0012131) | 2.46764548 |
| 47 | Arterial thrombosis (HP:0004420) | 2.46090212 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.45794660 |
| 49 | Increased IgM level (HP:0003496) | 2.45328129 |
| 50 | Periodontitis (HP:0000704) | 2.43817121 |
| 51 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.42383818 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41826175 |
| 53 | Obstructive lung disease (HP:0006536) | 2.41826175 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.39870674 |
| 55 | Loss of speech (HP:0002371) | 2.38572934 |
| 56 | Granulocytopenia (HP:0001913) | 2.36907258 |
| 57 | Abnormality of T cells (HP:0002843) | 2.36453635 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.35624775 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.34711821 |
| 60 | Gingival bleeding (HP:0000225) | 2.34626321 |
| 61 | Eosinophilia (HP:0001880) | 2.33970644 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.31816052 |
| 63 | Restrictive lung disease (HP:0002091) | 2.31814077 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.31753269 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.31008134 |
| 66 | Leukocytosis (HP:0001974) | 2.28776749 |
| 67 | Increased IgE level (HP:0003212) | 2.28231467 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.27624369 |
| 69 | Gingivitis (HP:0000230) | 2.27411404 |
| 70 | Testicular atrophy (HP:0000029) | 2.27080596 |
| 71 | Purpura (HP:0000979) | 2.23174193 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.20631321 |
| 73 | Chest pain (HP:0100749) | 2.18530499 |
| 74 | Seborrheic dermatitis (HP:0001051) | 2.17948307 |
| 75 | Hematochezia (HP:0002573) | 2.17715883 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16338712 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.16228903 |
| 78 | Encephalitis (HP:0002383) | 2.14405909 |
| 79 | Chronic sinusitis (HP:0011109) | 2.13869196 |
| 80 | Epistaxis (HP:0000421) | 2.13054465 |
| 81 | Basal ganglia calcification (HP:0002135) | 2.12903801 |
| 82 | Hemoptysis (HP:0002105) | 2.12023426 |
| 83 | Rhabdomyolysis (HP:0003201) | 2.10092309 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.08110347 |
| 85 | Osteomyelitis (HP:0002754) | 2.05697072 |
| 86 | Skin ulcer (HP:0200042) | 2.04864278 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.04223265 |
| 88 | Lymphopenia (HP:0001888) | 2.03948251 |
| 89 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02833131 |
| 90 | Villous atrophy (HP:0011473) | 2.02833131 |
| 91 | Bulbar palsy (HP:0001283) | 2.01949063 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.01343899 |
| 93 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01337905 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00661865 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00661865 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00661865 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00323876 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.00323876 |
| 99 | Fatigue (HP:0012378) | 2.00210300 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99396239 |
| 101 | Abnormality of eosinophils (HP:0001879) | 1.98478029 |
| 102 | J-shaped sella turcica (HP:0002680) | 1.98449611 |
| 103 | Recurrent pneumonia (HP:0006532) | 1.98446654 |
| 104 | Emphysema (HP:0002097) | 1.98037022 |
| 105 | Myocardial infarction (HP:0001658) | 1.97862644 |
| 106 | Skin rash (HP:0000988) | 1.97794897 |
| 107 | Flat acetabular roof (HP:0003180) | 1.97601388 |
| 108 | Verrucae (HP:0200043) | 1.97140644 |
| 109 | Papilloma (HP:0012740) | 1.97140644 |
| 110 | Neutropenia (HP:0001875) | 1.96061895 |
| 111 | Reticulocytopenia (HP:0001896) | 1.95511862 |
| 112 | Polycythemia (HP:0001901) | 1.94956537 |
| 113 | IgA deficiency (HP:0002720) | 1.93976758 |
| 114 | Increased muscle lipid content (HP:0009058) | 1.93285667 |
| 115 | Abnormality of T cell number (HP:0011839) | 1.93282563 |
| 116 | Increased serum ferritin (HP:0003281) | 1.92677726 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.91535431 |
| 118 | IgG deficiency (HP:0004315) | 1.89977467 |
| 119 | Peritonitis (HP:0002586) | 1.88490952 |
| 120 | Myopathic facies (HP:0002058) | 1.87603684 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86359200 |
| 122 | Thin bony cortex (HP:0002753) | 1.85876300 |
| 123 | Abnormal platelet function (HP:0011869) | 1.85809813 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.85809813 |
| 125 | Osteolytic defects of the hand bones (HP:0009699) | 1.85550864 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85550864 |
| 127 | Poor head control (HP:0002421) | 1.85360263 |
| 128 | Progressive neurologic deterioration (HP:0002344) | 1.84949421 |
| 129 | Exertional dyspnea (HP:0002875) | 1.84716043 |
| 130 | Progressive muscle weakness (HP:0003323) | 1.83928552 |
| 131 | Malnutrition (HP:0004395) | 1.83281519 |
| 132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82786017 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.81114802 |
| 134 | Polyneuropathy (HP:0001271) | 1.77491332 |
| 135 | Abnormality of the prostate (HP:0008775) | 1.77335421 |
| 136 | Anorexia (HP:0002039) | 1.76987119 |
| 137 | Axonal loss (HP:0003447) | 1.76091217 |
| 138 | Thoracic kyphosis (HP:0002942) | 1.75919163 |
| 139 | Chronic diarrhea (HP:0002028) | 1.74740149 |
| 140 | Prolonged bleeding time (HP:0003010) | 1.74726376 |
| 141 | Premature loss of primary teeth (HP:0006323) | 1.73370075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.37348898 |
| 2 | MAP4K1 | 3.20167960 |
| 3 | TBK1 | 2.89218297 |
| 4 | TYK2 | 2.84357554 |
| 5 | SMG1 | 2.77722817 |
| 6 | PIM2 | 2.67065005 |
| 7 | PRPF4B | 2.56239462 |
| 8 | IRAK4 | 2.54492114 |
| 9 | BLK | 2.48355736 |
| 10 | NME2 | 2.35874998 |
| 11 | ERN1 | 2.35177751 |
| 12 | IKBKB | 2.35172235 |
| 13 | JAK3 | 2.33991984 |
| 14 | KIT | 2.19366090 |
| 15 | IRAK3 | 2.16860628 |
| 16 | IKBKE | 2.01308627 |
| 17 | MAP2K3 | 1.84357248 |
| 18 | FLT3 | 1.82402313 |
| 19 | TAOK1 | 1.77383415 |
| 20 | CSF1R | 1.74073106 |
| 21 | EPHB1 | 1.71074861 |
| 22 | BTK | 1.70918814 |
| 23 | TAOK2 | 1.60420441 |
| 24 | CHUK | 1.60130892 |
| 25 | ZAP70 | 1.58202206 |
| 26 | LRRK2 | 1.57683855 |
| 27 | KDR | 1.49876977 |
| 28 | TEC | 1.48975856 |
| 29 | JAK1 | 1.45820598 |
| 30 | BCKDK | 1.42565761 |
| 31 | TGFBR2 | 1.42116186 |
| 32 | MST4 | 1.41805081 |
| 33 | RPS6KA4 | 1.39173694 |
| 34 | TRIB3 | 1.38333830 |
| 35 | TAOK3 | 1.38309832 |
| 36 | STK10 | 1.37833674 |
| 37 | VRK2 | 1.35028820 |
| 38 | SYK | 1.32822129 |
| 39 | NEK9 | 1.29725763 |
| 40 | FGFR4 | 1.25171651 |
| 41 | ICK | 1.21815817 |
| 42 | PIM1 | 1.21099168 |
| 43 | PKN2 | 1.19523135 |
| 44 | TTN | 1.16702773 |
| 45 | TNK2 | 1.09910781 |
| 46 | MST1R | 1.04546083 |
| 47 | MAP3K3 | 1.03187077 |
| 48 | TGFBR1 | 1.01898240 |
| 49 | RIPK4 | 0.99305267 |
| 50 | TESK2 | 0.96535950 |
| 51 | MAP3K1 | 0.94716141 |
| 52 | SCYL2 | 0.94267874 |
| 53 | CSK | 0.94019811 |
| 54 | PIK3CG | 0.93993293 |
| 55 | TXK | 0.93580916 |
| 56 | STK4 | 0.93553205 |
| 57 | MATK | 0.92570669 |
| 58 | PRKD2 | 0.90452100 |
| 59 | EIF2AK3 | 0.90395719 |
| 60 | EEF2K | 0.88801678 |
| 61 | PAK4 | 0.86988990 |
| 62 | NLK | 0.86440909 |
| 63 | STK16 | 0.85810676 |
| 64 | LYN | 0.85659655 |
| 65 | JAK2 | 0.84761225 |
| 66 | EPHA3 | 0.83630166 |
| 67 | PTK6 | 0.81943951 |
| 68 | MAP3K13 | 0.79890714 |
| 69 | ITK | 0.79722889 |
| 70 | PDPK1 | 0.79635546 |
| 71 | LCK | 0.79210711 |
| 72 | CDK12 | 0.78962717 |
| 73 | RPS6KB2 | 0.76640276 |
| 74 | TLK1 | 0.75499565 |
| 75 | MAP3K11 | 0.73512612 |
| 76 | EIF2AK1 | 0.73451978 |
| 77 | MAPKAPK3 | 0.72281614 |
| 78 | HCK | 0.70669580 |
| 79 | IRAK2 | 0.70376896 |
| 80 | TESK1 | 0.69635673 |
| 81 | MAPKAPK2 | 0.69432134 |
| 82 | ABL2 | 0.67894130 |
| 83 | PRKCI | 0.67083647 |
| 84 | CDC42BPA | 0.66619018 |
| 85 | DAPK1 | 0.65680582 |
| 86 | MAP3K8 | 0.63533737 |
| 87 | MYLK | 0.61855141 |
| 88 | VRK1 | 0.61599966 |
| 89 | NME1 | 0.58470745 |
| 90 | MAP2K6 | 0.57883635 |
| 91 | RIPK1 | 0.57474818 |
| 92 | HIPK2 | 0.57319450 |
| 93 | PDK1 | 0.57150020 |
| 94 | GRK6 | 0.57025506 |
| 95 | ACVR1B | 0.55060017 |
| 96 | TRPM7 | 0.53425909 |
| 97 | ILK | 0.53294841 |
| 98 | BUB1 | 0.51821637 |
| 99 | CDK4 | 0.51795916 |
| 100 | CAMK1D | 0.51723782 |
| 101 | EIF2AK2 | 0.51518715 |
| 102 | MAP2K2 | 0.51043471 |
| 103 | CLK1 | 0.51019428 |
| 104 | RPS6KC1 | 0.50730417 |
| 105 | RPS6KL1 | 0.50730417 |
| 106 | SIK1 | 0.47035798 |
| 107 | DYRK3 | 0.46750089 |
| 108 | RPS6KA6 | 0.45853082 |
| 109 | PRKCD | 0.45475565 |
| 110 | MAP3K10 | 0.45145603 |
| 111 | STK24 | 0.44371513 |
| 112 | DAPK3 | 0.44229470 |
| 113 | FES | 0.42253060 |
| 114 | MAPK11 | 0.42119675 |
| 115 | WEE1 | 0.41747327 |
| 116 | FGR | 0.41665063 |
| 117 | RPS6KA2 | 0.41375533 |
| 118 | BMPR2 | 0.40996917 |
| 119 | CDK7 | 0.40066276 |
| 120 | MARK2 | 0.39980949 |
| 121 | ARAF | 0.39755476 |
| 122 | PBK | 0.38738778 |
| 123 | ABL1 | 0.38236205 |
| 124 | RPS6KA5 | 0.37609422 |
| 125 | TIE1 | 0.37434854 |
| 126 | MAPK12 | 0.34796433 |
| 127 | IRAK1 | 0.34070209 |
| 128 | SIK3 | 0.33883299 |
| 129 | SIK2 | 0.33861348 |
| 130 | BRSK2 | 0.33649230 |
| 131 | EPHA2 | 0.33584946 |
| 132 | MARK3 | 0.32886200 |
| 133 | PRKD1 | 0.32399863 |
| 134 | DYRK1B | 0.32211867 |
| 135 | PRKCQ | 0.30883200 |
| 136 | MTOR | 0.30429933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50413272 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33228602 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32802059 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.32795307 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.29681121 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25687711 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22830781 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20429072 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.11867524 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.09088594 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85166564 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80578335 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.80505425 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77488253 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.76788201 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.76058315 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70211275 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63719045 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56412220 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53178314 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52757377 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51918877 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51759211 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48891263 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43017370 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.40218823 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.37934562 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.37559910 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36742201 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.31048390 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26005989 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.23690599 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.19510987 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.18657392 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17223168 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.15498202 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14769512 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14381761 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14024447 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13909919 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13235461 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12447559 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09371063 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08436692 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.06777498 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.05533153 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02731392 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02471632 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.98456111 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96574958 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96365020 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92884797 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91521843 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.88177403 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87017664 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82070301 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81863989 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81156448 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.80834573 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80301307 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78873211 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.77080174 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76238105 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74323312 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74041664 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73754120 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73541829 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72803519 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71181719 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69493103 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68749816 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68732640 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.68027885 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65950461 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.64589855 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63805230 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61929222 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60108562 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59878322 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59599753 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58714403 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58494550 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57955878 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57890870 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56763686 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55913823 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55868944 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55270415 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55258583 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54839314 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52629184 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52318909 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52154645 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51672508 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51127165 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50768770 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50591141 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50287177 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49092921 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48789772 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48782325 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48143844 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.48026150 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47809108 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46485203 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46438504 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46121644 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45666063 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45369594 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44272681 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44244773 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.43869248 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42366125 |
| 114 | RNA polymerase_Homo sapiens_hsa03020 | 0.41512433 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41300574 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.41194879 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41079645 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40998259 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40627771 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40434078 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40277883 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.39765067 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39703440 |
| 124 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39319172 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.38077876 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31679522 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.29753692 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29133362 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26944756 |

